Steven Valiquette
Stock Analyst at Barclays
(2.23)
# 2,567
Out of 4,670 analysts
93
Total ratings
58.14%
Success rate
2.95%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Equal-Weight | $18 → $14 | $12.35 | +13.36% | 7 | Nov 5, 2024 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $142 | $197.94 | -28.26% | 10 | Sep 21, 2023 | |
| VTR Ventas | Maintains: Overweight | $55 | $63.55 | -13.45% | 6 | Aug 4, 2023 | |
| WELL Welltower | Maintains: Overweight | $82 → $92 | $137.91 | -33.29% | 10 | Aug 2, 2023 | |
| CAH Cardinal Health | Maintains: Equal-Weight | $80 → $85 | $121.84 | -30.24% | 5 | Jun 12, 2023 | |
| UNH UnitedHealth Group | Maintains: Overweight | $565 | $590.87 | -4.38% | 5 | Apr 14, 2023 | |
| CVS CVS Health | Maintains: Overweight | $110 → $100 | $58.01 | +72.38% | 1 | Mar 30, 2023 | |
| MPW Medical Properties Trust | Maintains: Overweight | $17 → $14 | $4.31 | +224.83% | 1 | Feb 27, 2023 | |
| MOH Molina Healthcare | Maintains: Overweight | $380 → $400 | $290.79 | +37.56% | 4 | Oct 28, 2022 | |
| CNC Centene | Reinstates: Overweight | $107 | $60.37 | +77.24% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $30.30 | -43.89% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $5.48 | +118.98% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $475 → $555 | $225.89 | +145.69% | 9 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $101.12 | -5.06% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $40 | $18.77 | +113.11% | 5 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $166 | $623.19 | -73.36% | 2 | Nov 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $163.59 | -26.65% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $324.93 | -60.91% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $58 → $57 | $75.08 | -24.08% | 4 | Mar 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $298.11 | +20.09% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $20 → $16 | $20.46 | -21.80% | 3 | Aug 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $8.66 | +592.84% | 3 | Apr 3, 2019 |
Owens & Minor
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $12.35
Upside: +13.36%
Universal Health Services
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $197.94
Upside: -28.26%
Ventas
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $63.55
Upside: -13.45%
Welltower
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $137.91
Upside: -33.29%
Cardinal Health
Jun 12, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $121.84
Upside: -30.24%
UnitedHealth Group
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $590.87
Upside: -4.38%
CVS Health
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $58.01
Upside: +72.38%
Medical Properties Trust
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $4.31
Upside: +224.83%
Molina Healthcare
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $290.79
Upside: +37.56%
Centene
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $60.37
Upside: +77.24%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $30.30
Upside: -43.89%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $5.48
Upside: +118.98%
Feb 4, 2021
Maintains: Equal-Weight
Price Target: $475 → $555
Current: $225.89
Upside: +145.69%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $101.12
Upside: -5.06%
Nov 17, 2020
Downgrades: Underweight
Price Target: $40
Current: $18.77
Upside: +113.11%
Nov 2, 2020
Upgrades: Overweight
Price Target: $166
Current: $623.19
Upside: -73.36%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $163.59
Upside: -26.65%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $324.93
Upside: -60.91%
Mar 31, 2020
Maintains: Equal-Weight
Price Target: $58 → $57
Current: $75.08
Upside: -24.08%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $298.11
Upside: +20.09%
Aug 30, 2019
Maintains: Underweight
Price Target: $20 → $16
Current: $20.46
Upside: -21.80%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $8.66
Upside: +592.84%